The global Peripheral Vascular Device Market is poised for significant expansion in the coming years, driven by a rising geriatric population, increasing incidence of peripheral artery disease (PAD), technological advancements in minimally invasive treatment options, and the growing adoption of endovascular devices. As healthcare systems around the world continue to prioritize early detection and effective management of vascular disorders, the demand for next-generation peripheral vascular devices has reached new heights.
Global Peripheral Vascular Device Market size and share is currently valued at USD 10.67 billion in 2024 and is anticipated to generate an estimated revenue of USD 18.51 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 5.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034
Market Overview
Peripheral vascular devices are used in diagnosing and treating conditions that affect blood vessels outside of the heart and brain. These include arteries and veins in the limbs, stomach, and kidneys. With the increasing prevalence of lifestyle-related diseases such as diabetes, obesity, and hypertension, the number of patients requiring vascular intervention has seen a sharp rise globally.
Key categories of peripheral vascular devices include:
-
Angioplasty balloons and stents
-
Atherectomy devices
-
Embolic protection devices
-
Chronic total occlusion (CTO) devices
-
Vena cava filters
-
Synthetic grafts and patches
Modern peripheral vascular procedures are characterized by reduced patient recovery time, minimal trauma, and high success rates, all of which contribute to their widespread adoption across both developed and developing economies.
Market Segmentation
By Product Type:
-
Angioplasty Balloons (Drug-Coated, Normal, Scoring, Cutting)
-
Stents (Drug-Eluting, Bare Metal, Covered)
-
Atherectomy Devices
-
Peripheral Guidewires
-
Vena Cava Filters
-
Embolic Protection Devices
-
Synthetic Grafts
-
Hemostatic Devices
-
Inferior Vena Cava Filters
By Application:
-
Peripheral Artery Disease
-
Deep Vein Thrombosis
-
Aneurysms
-
Varicose Veins
-
Chronic Venous Insufficiency
By End-User:
-
Hospitals
-
Ambulatory Surgical Centers (ASCs)
-
Specialty Clinics
-
Academic & Research Institutes
By Technology:
-
Minimally Invasive Devices
-
Open Surgical Devices
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/global-peripheral-vascular-device-market
Country-Wise Market Trends
United States
The U.S. leads the peripheral vascular device market in terms of technological innovation, procedure volumes, and healthcare spending. With a large aging population and high rates of PAD and diabetes, the country sees extensive demand for vascular intervention tools and angioplasty procedures.
Hospitals and ASCs across the U.S. are increasingly adopting minimally invasive treatment options such as drug-coated balloons and stents, driven by favorable reimbursement scenarios and FDA approvals. Key cities like New York, Los Angeles, and Chicago have become hubs for clinical trials and device innovation, with local manufacturers playing a pivotal role in global exports.
Germany
Germany remains at the forefront of Europe’s vascular care sector. With a robust healthcare infrastructure and strong research and development backing, the country has become a major adopter of endovascular devices and atherectomy tools.
The German government’s support for early screening and interventional therapy for PAD and chronic venous disease has made minimally invasive treatment a standard protocol. High procedural volumes and training programs for vascular surgeons continue to support market growth in cities like Berlin, Munich, and Hamburg.
France
France shows consistent demand for peripheral vascular devices, fueled by an aging population and rising vascular disease cases. Government healthcare reforms have encouraged the use of drug-eluting stents and embolization devices to reduce recurrence rates and hospital stays.
French hospitals increasingly rely on endovascular devices for treating aneurysms and venous thromboembolism (VTE), supported by collaborations with European medical device firms and academic research institutes.
United Kingdom
The UK is witnessing increased investment in vascular care, particularly in NHS-funded screening and treatment programs. Adoption of peripheral vascular intervention has expanded beyond tertiary care hospitals to regional and district hospitals, thanks to efforts to reduce wait times and hospital burden.
The popularity of angioplasty procedures continues to grow, especially for treating peripheral artery disease, with newer-generation balloons and stents receiving widespread clinical endorsement.
China
China represents one of the fastest-growing markets for peripheral vascular devices. Urbanization, lifestyle changes, and increased awareness of cardiovascular health have driven significant demand for minimally invasive treatment of PAD, varicose veins, and deep vein thrombosis.
In cities like Beijing and Shanghai, healthcare reforms have led to greater investments in medical technology infrastructure, expanding access to endovascular devices. Domestic manufacturers are rapidly scaling up production and innovation to compete globally, aided by supportive government policies.
India
India's vascular device market is emerging rapidly due to a growing population suffering from diabetes and vascular complications. In urban centers like Mumbai, Delhi, and Bengaluru, rising income levels and improved healthcare access have boosted demand for advanced angioplasty procedures and atherectomy devices.
Challenges such as cost sensitivity and lack of skilled vascular surgeons in rural areas remain, but national health schemes and training programs are attempting to bridge the gap.
Brazil
Brazil’s peripheral vascular device market is shaped by a dual demand from public hospitals and a growing private healthcare sector. Rising rates of venous disease and PAD are creating opportunities for endovascular procedures, particularly in metropolitan areas like São Paulo and Rio de Janeiro.
With a strong presence of international medical device firms, Brazil is benefitting from imports and technology transfer, although local manufacturing remains limited.
United Arab Emirates
In the UAE, demand for vascular intervention tools is increasing as part of broader initiatives to reduce lifestyle-related diseases and improve healthcare quality. Cities like Dubai and Abu Dhabi are investing in world-class vascular centers equipped with minimally invasive treatment capabilities, attracting both residents and medical tourists.
The market is supported by strategic partnerships with global medical device firms and a focus on early diagnosis and outpatient care models.
Key Companies
The peripheral vascular device market is characterized by the presence of major multinational corporations and innovative mid-sized players. Competition centers on technological advancement, portfolio diversification, and strategic collaborations.
Medtronic plc (Ireland)
A global leader in endovascular devices, Medtronic offers a broad range of angioplasty balloons, stents, and embolic protection devices. Its product innovations in drug-coated balloons and stent systems are widely used in both developed and emerging markets.
Boston Scientific Corporation (USA)
Boston Scientific is known for its robust line of peripheral vascular intervention tools, including the Ranger™ DCB and Eluvia™ stent systems. The company emphasizes research, clinical validation, and physician training.
Abbott Laboratories (USA)
Abbott's vascular division offers cutting-edge angioplasty procedures tools, including balloon catheters, guidewires, and closure devices. Its global distribution network and R&D investments make it a key player in both hospital and outpatient settings.
B. Braun Melsungen AG (Germany)
With a strong European presence, B. Braun focuses on minimally invasive treatment solutions, including vascular grafts, filters, and angioplasty catheters. The company is also active in physician training and education.
Terumo Corporation (Japan)
Terumo's portfolio includes endovascular devices used in neurovascular and peripheral procedures. The company has a strong footprint in Asia-Pacific, with growing influence in North America and Europe.
Cardinal Health (USA)
Through its Cordis division, Cardinal Health offers innovative vascular intervention products including diagnostic and interventional catheters. The company's strength lies in global distribution and value-based healthcare solutions.
Other notable players include:
-
Cook Medical
-
Philips Healthcare
-
Endologix LLC
-
AngioDynamics Inc.
-
iVascular SLU
These companies continue to drive market innovation through partnerships, clinical trials, and product diversification, with a focus on improving patient outcomes and reducing procedure time.
Conclusion
The Peripheral Vascular Device Market stands at the forefront of global healthcare transformation, empowered by the growing preference for minimally invasive treatment, early disease detection, and the proliferation of endovascular devices. As healthcare systems strive for cost efficiency, improved outcomes, and patient-centric care, the demand for advanced vascular intervention tools will only intensify.
Supported by technological breakthroughs, country-specific health reforms, and robust R&D, the market offers vast potential for device manufacturers, investors, and healthcare providers alike.
More Trending Reports by Polaris Market Research:
Autoimmune Disease Diagnostics Market
Optical Coherence Tomography (Oct) Market
Hemodynamic Monitoring Devices Market
Narcolepsy Therapeutics Market
Bipolar Disorder Treatment Market
Brain Tumor Diagnosis and Therapeutics Market
Healthcare Cybersecurity Market
Needle Free Iv Connectors Market
Breast Cancer Liquid Biopsy Market
Nonmydriatic Fundus Cameras Market
Top Bioreactor Manufacturers in 2024: Simplifying Chemicals and Biological Reactions
Biochip Companies: An effective procedure in decoding genes